InsiderClue
Insiders · Profile

Cohen Fred E

Director at Intellia Therapeutics · Director at VERACYTE · Director at BIOCRYST PHARMACEUTICALS. Filing since 18 Sep 2017. CIK 0001339358

NTLA Intellia Therapeutics, Inc. Director · 1 trade VCYT VERACYTE, INC. Director · 1 trade BCRX BIOCRYST PHARMACEUTICALS INC Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
5 Jan 2026
Director
Bought
150,000
$1.40M
261%
VCYT VERACYTE, INC.
18 May 2020
Director
Sold, plan not stated
40,000
$1.07M
100%
BCRX BIOCRYST PHARMACEUTICALS INC
18 Sep 2017
Director
Sold, plan not stated
54,250
$294.04K
31.2%
3 decisions on file.